UK approves Regeneron/Roche antibody cocktail for COVID-19

New drug Ronapreve promises to stop COVID in its tracks

There is fresh hope in the war on COVID-19 with the approval of an antibody cocktail developed by Regeneron and Roche to prevent and treat COVID

UK Regulator Approves Antibody Drug Ronapreve to Prevent, Tackle Covid

Ronapreve is the first monoclonal antibody combination product indicated for use in the prevention and treatment of acute COVID19 infection for the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) said.

Covid-19 news: UK approves first-of-its-kind antibody treatment

The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic

AstraZeneca's antibody therapy prevents COVID-19, study shows

AstraZeneca's new antibody therapy reduced the risk of people developing COVID-19 symptoms by 77% in a late-stage trial, putting the drugmaker on track to offer protection to those who respond poorly to vaccines. Read More

'Fantastic news': UK approves first ever Covid antibody treatment

A UK medicines regulator, Medicines and Healthcare products Regulatory Agency (MHRA), has approved the use of artificial antibodies to prevent COVID-19. As per the experts of MHRA, Ronapreve might be able to prevent people from coronavirus infections and may also be able to treat the patients who are suffering from acute symptoms of coronavirus. This treatment might also reduce the chances of getting admitted in the hospital due to the coronavir…

Covid-antibody therapy approved in UK

Antibody therapy - given to former US President Donald Trump - can now be used in the UK.